Gray Almasi, 1L Representative, SELS, January 2026
When the Enhanced Games debuts in Las Vegas in May 2026, it will not simply give the world a glimpse into “The Future of Human Performance,” it will test the limits of how far sport can diverge from its traditional regulatory foundations before it ceases to be recognizable as such. Framed as a celebration of “human potential,” the Games will permit international athletes to use performance-enhancing drugs (PEDs) during competition, so long as they are approved by the U.S. Food and Drug Administration (FDA) and administered under medical supervision. Since 2023, Australian entrepreneur, lawyer, and founder of the Enhanced Games, Aron D’Souza, has been luring top-level athletes from across the world with incentives of the total prize money reportedly reaching $25 million, and individual rewards of up to $1 million for record-breaking performances, with the upcoming event positioning itself at the intersection of sport, science, and spectacle.
Yet beyond these incentives lies a far more consequential issue. The Enhanced Games do not merely challenge anti-doping rules; they raise questions about the legal foundations of modern sport. As a result, tensions emerge between private regulation, public law, athlete autonomy, and commercial risk, tensions that could ultimately reshape the global sporting landscape.
A Fundamentally Different Sporting Model
Unlike traditional international competitions, the Enhanced Games do not seek to reform existing sporting structures but rather operate as a parallel system that explicitly rejects the authority of international federations and anti-doping bodies. The Games are expected to feature world-class athletes from fourteen different countries competing in swimming, track, and weightlifting, with events such as freestyle and butterfly races, the 100-metre sprint and hurdles, and the snatch and clean & jerk.
Brought to the media in April 2025, the regulatory division from traditional international sporting events drew attention when Greek swimmer Kristian Gkolomeev broke a 17-year-old 50-metre freestyle record during an Enhanced Games-affiliated event. Organizers asserted that Gkolomeev’s swim took place in a certified North Carolina pool, employing Olympic-standard timing technology and experienced officials. Nevertheless, World Aquatics (WA) has refused to recognize the performance, reaffirming that records achieved under enhanced conditions fall outside the existing regulatory framework.
British sprinter Adam Gemili, for example, has indicated willingness to compete at the Enhanced Games without using performance-enhancing substances. Even though this would comply with the Games’ rules, it would exclude him from the protections and recognition of traditional sporting bodies. This illustrates that simple association with the Enhanced Games, regardless of drug use, results in regulatory exclusion from mainstream competitions. Governing bodies view the event as a private commercial product, not a regulated public competition, regardless of an athlete’s individual choices.
On the other side of this international divide, the Games’ organizers defend their model by reorienting drug regulation away from prohibition and toward health monitoring. Proponents argue that this is a transparent, supervised approach that is safer and more honest than existing anti-doping regimes, which they claim incentivize covert misuse.
Institutional Resistance and the Limits of Antitrust Law
Unsurprisingly, established governing bodies have responded with decisive resistance. In June 2025, World Aquatics announced a blanket ban preventing any swimmer, coach, or official involved with the Enhanced Games from participating in its sanctioned events, regardless of whether they personally engaged in doping. The disapproval of the Games from international sport governing bodies is no secret, with a statement from World Aquatics reading, “The Enhanced Games are not a sporting competition built on universal values like honesty, fairness and equity: they are a circus, building on shortcuts.” Similar opposition has been expressed by the World Anti-Doping Agency (WADA) and USA Swimming, each arguing that the Games undermine decades of progress in athlete welfare and competitive integrity.
The Enhanced Games responded by filing an $800 million antitrust lawsuit, alleging that these organizations unlawfully conspired to restrict athlete participation and suppress competition. In late 2025, a U.S. federal judge dismissed the claim, concluding the complaint lacked sufficient evidence of anticompetitive conduct. Organizers were granted leave to amend. The ruling reflects a broader judicial reluctance to interfere with the regulatory autonomy of international sports bodies, especially when restrictions are justified by concerns about athlete safety and integrity.
The dismissal underscores that antitrust law offers little protection when exclusion rests on longstanding governance, rather than clear commercial collusion.
Athlete Autonomy, Consent, and Legal Exposure
A key defence for the Enhanced Games is athlete autonomy. Organizers argue that informed consent and medical supervision provide an ethical, transparent approach to enhancement, contrasting with anti-doping regimes, which they claim promote covert misuse. By making enhancement a monitored health choice rather than a forbidden act, they claim to focus on welfare over punishment.
From a legal perspective, however, consent alone does not protect organizers from liability. Athletes’ voluntary assumption of risk does not prevent organizers from being liable under negligence, occupational safety, or public health law, especially if enhancement protocols cause long-term harm. Unlike traditional doping, which assigns responsibility to individuals and occurs outside institutional oversight, the Enhanced Games’ structured, medically supervised approach could expose event organizers, medical professionals, and corporate partners to legal risks.
This exposure is heightened by current scientific uncertainty surrounding the health effects of performance-enhancing drugs. A study published in May 2025 by the University of Birmingham highlights that evidence on the long-term cardiovascular, reproductive, and cognitive consequences of PED use remains limited and largely observational, with insufficient data to establish reliable dose-response relationships or definitive safety thresholds. While harm-reduction models may monitor biomarkers in the short term, they cannot eliminate the risk of delayed or cumulative harm, particularly where substances are used at supraphysiological levels.
These evidentiary gaps have direct legal consequences. If an athlete suffers serious health outcomes, such as cardiac complications or hormonal dysfunction, organizers could face negligence claims grounded in a failure to adequately warn, a failure to mitigate foreseeable risk, or a breach of the duty of care owed to participants. Crucially, uncertainty in the medical literature does not insulate organizers from liability; it may strengthen arguments that permitting enhancement without robust safety evidence falls below an acceptable standard of care.
Further complications arise under public health and drug laws. Some substances, while approved for therapy, may be off-label for performance, potentially triggering regulatory scrutiny or criminal action, depending on jurisdiction. This risk is more pronounced in international contests where overlapping laws apply.
Taken together, these issues suggest that athlete consent, while central to the Enhanced Games’ ethical narrative, does not eliminate legal risks. By institutionalizing enhancement, the Games may concentrate liability on organizers, turning individual health choices into organizational legal exposure.
Commercial Fallout and Contractual Risk
Competing in the Enhanced Games brings major commercial risks. Many elite athletes’ sponsorship deals include morality or reputation clauses that could be triggered by joining a competition condemned by sport’s major bodies. Even if legal, reputational harm can be grounds for termination.
The same uncertainty impacts broadcasters, sponsors, and insurers. Traditional insurers may avoid backing events that facilitate enhancement, which could raise premiums or limit coverage. This limits broadcasting and partnerships, raising questions about the Games’ long-term financial viability despite headline prize money and high-profile backing.
Intellectual property and data ownership present further challenges. The Games’ focus on performance metrics and medical monitoring raises questions about who owns and can monetize athlete data from enhancement protocols, an issue largely underexplored in sports law.
A Stress Test for Global Sport
Whether the Enhanced Games succeed as a commercial venture remains uncertain. What is already clear, however, is their legal significance. By deliberately operating outside established regulatory frameworks, the Games expose the fragility of the consensus that underpins global sport, one built as much on tradition and voluntary compliance as on enforceable law.
Anti-doping systems have long been justified on the grounds of fairness, safety, and public trust. The Enhanced Games challenge that doctrine, arguing that transparency and medical oversight are preferable to prohibition and punishment. Courts and regulators now face difficult questions: where does athlete autonomy end, and regulatory responsibility begin? How far can private organizers deviate from accepted norms before intervention becomes necessary?
In attempting to redefine elite sport, the Enhanced Games may ultimately redefine the legal boundaries that govern it. Whether they are remembered as a bold innovation or a cautionary tale, their impact on international sport regulations will extend far beyond Las Vegas.
Works Cited
Enhanced US LLC v World Aquatics, World Anti-Doping Agency, and USA Swimming [2025] SDNY (Case 1:25-cv-07096-JMF)
“Enhanced.” Enhanced Games, http://www.enhanced.com/.
“Enhanced Games Files $800 Million Antitrust Lawsuit against World Aquatics, the World Anti- Doping Agency and USA Swimming – Enhanced.” Enhanced Games, 27 Aug. 2025, http://www.enhanced.com/newsroom/enhanced-games-files-800-million-antitrust-lawsuit-against-world-aquatics-the-world-anti-doping-agency-and-usa-swimming.
“Enhanced Games Files $800 Million Antitrust Lawsuit against World Aquatics, the World Anti- Doping Agency and USA Swimming – Enhanced.” Enhanced Games, 27 Aug. 2025, http://www.enhanced.com/newsroom/enhanced-games-files-800-million-antitrust-lawsuit-against-world-aquatics-the-world-anti-doping-agency-and-usa-swimming.
“Enhanced Games Lawsuit against World Aquatics, Wada and USA Swimming Dismissed.” Sport Resolutions, 21 Nov. 2025, http://www.sportresolutions.com/news/enhanced-games-lawsuit-dismissed.
“Enhanced Games Lawsuit against Sports Bodies Dismissed.” Fox Mandal, 15 Jan. 2026, foxmandal.in/News/enhanced-games-lawsuit-against-sports-bodies-dismissed/.
Martin Chandler, Ian Boardley, Harm reduction in the Enhanced Games: Can performance enhancing drugs be ‘safe’?, Performance Enhancement & Health, Volume 13, Issue 3, 2025, 100341, ISSN 2211-2669, https://doi.org/10.1016/j.peh.2025.100341.
Colman, Jonty. “What Are the Enhanced Games?” BBC Sport, BBC, 10 Sept. 2025, http://www.bbc.co.uk/sport/articles/c1j5w5kgn50o.
Armstrong, Simon. “Enhanced Games Sprinter Reece Prescod ‘not Taking Drugs’ for Las Vegas Event.” BBC Sport, BBC, 13 Jan. 2026, http://www.bbc.co.uk/sport/athletics/articles/clygr0llzdeo.
Henson, Mike. “Enhanced Games: Doped Swimmer Claims 50m Freestyle ‘World Record.’” BBC Sport, BBC, 21 May 2025, http://www.bbc.co.uk/sport/swimming/articles/c629996lnkro.